Hypertension in China: A large and increasing public health challenge

Journal of Hypertension

Volumn 34, Issue 1, 2016, Pages 29-31

  He, Jiang ^a  

^a TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE MEASUREMENT; CHINA; CHINESE; ECONOMIC DEVELOPMENT; HUMAN; HYPERTENSION; MERCURY SPHYGMOMANOMETER; NOTE; PRIORITY JOURNAL; RURAL POPULATION; URBAN POPULATION;

EID: 84950116744     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000818     Document Type: Note

References (15)

1. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, et al. Major causes of death among men and women in China. N Engl J Med 2005; 353:1124-1134.
2. He J, Gu D, Chen J, Wu X, Kelly TN, Huang JF, et al. Premature deaths attributable to blood pressure in China: a prospective cohort study. Lancet 2009; 374:1765-1772.
3. Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 2008; 118:2679-2686.
4. Li YC, Wang LM, Jiang Y, Li XY, Zhang M, Hu N. Prevalence of hypertension among Chinese adults in 2010. Chin J Prev Med (Chinese) 2012; 46:409-413.
5. Xu Y, Bi Y, Li M, Wang W, Wang T, Wang L, et al. Prevalence, awareness, treatment, and control of hypertension in China. Circulation 2013; 127:A005.
6. Gao Y, Chen G, Tian H, Lin L, Lu J, Weng J, et al. Prevalence of hypertension in China: a cross-sectional study. PLoS One 2013; 8:e65938.
7. Wang J, Zhang L, Wang F, Liu L, Wang H, China National Survey of Chronic Kidney Disease Working Group. Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens 2014; 27:1355-1361.
8. Li W, Gu H, Teo K, Bo J, Wang Y, Yang J, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China. J Hypertens 2016; 34:39-46.
9. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013; 310:959-968.
10. Li D, Lv J, Liu F, Liu P, Yang X, Feng Y, et al. Hypertension burden and control in mainland China: analysis of nationwide data 2003-2012. Int J Cardiol 2015; 184:637-644.
11. Reynolds K, Gu D, Muntner P, Wu X, Chen J, Huang G, et al. Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens 2003; 21:1273-1281.
12. Wang X, Bots ML, Yang F, Hoes AW, Vaartjes I. Prevalence of hypertension in China: a systematic review and meta-regression analysis of trends and regional differences. J Hypertens 2014; 32:1919-1927.
13. Zhao L, Stamler J, Yan LL, Zhou B, Wu Y, Liu K, et al. Blood pressure differences between northern and southern Chinese: role of dietary factors: the International Study on Macronutrients and Blood Pressure. Hypertension 2004; 43:1332-1337.
14. Neal B, MacMahon S, Chapman N, Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000; 356:1955-1964.
15. Gu D, He J, Coxson PG, Rasmussen PW, Huang C, Thanataveerat A, et al. The cost-effectiveness of low-cost essential antihypertensive medicines for hypertension control in China: a modelling study. PLoS Med 2015; 12:e1001860.